Overall, 5.7 percent of participants with MCI had one-year risk for any indication for anticoagulant and thrombolytic drugs ...

Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...

In ACS Central Science, researchers report the discovery of a snail-derived compound that blocks clot formation while still ...

For more than a century, heparin has been the go-to anticoagulant to prevent harmful blood clots in blood vessels or the heart from forming or getting larger. However, a major side effect is an ...

Sickle cell disease specialists face higher burnout rates than peers, impacting patient care and highlighting the need for systemic support in healthcare.